Arteriosclerosis and Thrombosis, Vol 14, 944-950, Copyright © 1994 by American Heart Association

ARTICLES

Cyclosporin suppresses transplant arteriosclerosis in the aorta- allografted, cholesterol-clamped rabbit. Suppression preceded by decrease in arterial lipoprotein permeability

HO Andersen, G Madsen, BG Nordestgaard, BF Hansen, K Kjeldsen and S Stender
Department of Clinical Biochemistry, Rigshospitalet, Copenhagen O, Denmark.

The immunosuppressant cyclosporin has been suggested to aggravate as well as retard the development of transplant arteriosclerosis, the major long-term problem for patients with heart transplants. We examined the effect of human therapeutic levels of blood cyclosporin on the development of experimental transplant arteriosclerosis. The thoracic aorta from one rabbit was transplanted as an end-to-side bypass on the abdominal aorta of another rabbit, and plasma cholesterol was clamped at 5 to 7 mmol/L. Cyclosporin markedly suppressed the severity of transplant arteriosclerosis, judged both biochemically and histologically: cholesterol content in aortic transplants was reduced by 70% and 80% after 10 days and 20 days of cholesterol feeding, respectively (both comparisons, P < .01), and after 20 days of cholesterol feeding myointimal proliferation was totally inhibited in grafts from cyclosporin-treated animals, judged from maximal intimal thickness and intimal area on cross sections of grafts (both comparisons, P < .05). In another group of non-cholesterol-fed, aorta- transplanted rabbits, cyclosporin reduced by 90% (P < .01) an otherwise markedly increased permeability to low-density lipoprotein in transplanted aortas. These results suggest that cyclosporin causes a substantial decrease in the severity of transplant arteriosclerosis and that this effect is mediated at least partly via a large decrease in aortic lipoprotein permeability.

This article has been cited by other articles:

				G. J. Schroepfer Jr. Oxysterols: Modulators of Cholesterol Metabolism and Other Processes Physiol Rev, January 1, 2000; 80(1): 361 - 554. [Abstract] [Full Text] [PDF]

				H. O. Andersen, B. F. Hansen, P. Holm, S. Stender, and B. G. Nordestgaard Effect of Cyclosporine on Arterial Balloon Injury Lesions in Cholesterol-Clamped Rabbits : T Lymphocyte–Mediated Immune Responses Not Involved in Balloon Injury–Induced Neointimal Proliferation Arterioscler Thromb Vasc Biol, July 1, 1999; 19(7): 1687 - 1694. [Abstract] [Full Text] [PDF]

				A. L. Armesilla, E. Lorenzo, P. Gomez del Arco, S. Martinez-Martinez, A. Alfranca, and J. M. Redondo Vascular Endothelial Growth Factor Activates Nuclear Factor of Activated T Cells in Human Endothelial Cells: a Role for Tissue Factor Gene Expression Mol. Cell. Biol., March 1, 1999; 19(3): 2032 - 2043. [Abstract] [Full Text] [PDF]

				H. O. Andersen, P. Holm, S. Stender, B. F. Hansen, and B. G. Nordestgaard Dose-Dependent Suppression of Transplant Arteriosclerosis in Aorta-Allografted, Cholesterol-Clamped Rabbits : Suppression Not Eliminated by the Cholesterol-Raising Effect of Cyclosporine Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2515 - 2523. [Abstract] [Full Text]

				P. Holm, S. Stender, H. o. Andersen, B. F. Hansen, and B. G. Nordestgaard Antiatherogenic Effect of Estrogen Abolished by Balloon Catheter Injury in Cholesterol-Clamped Rabbits Arterioscler Thromb Vasc Biol, August 1, 1997; 17(8): 1504 - 1511. [Abstract] [Full Text]

				K. B. Lemstrom, A. K. Raisanen-Sokolowski, P. J. Hayry, and P. K. Koskinen Triple Drug Immunosuppression Significantly Reduces Aortic Allograft Arteriosclerosis in the Rat Arterioscler Thromb Vasc Biol, April 1, 1996; 16(4): 553 - 564. [Abstract] [Full Text]